Purdue researchers developed a mass spectrometry platform that accelerates cancer drug discovery by integrating synthesis, ...

Researchers at the Purdue Institute for Cancer Research (PICR) have developed a next-generation technology platform designed ...

Drug discoverers are among customers Nvidia has pinpointed for its recently launched catalog of pretrained, customizable workflows enabling enterprise-level users to make their own artificial ...

Workflow Services, a platform to enable pharmacist-led clinical services, has completed a one-year pilot program and is expanding its Colorectal Cancer Screening Education Program. The goal of this ...

Explore how AI phenotypic screening transforms image-based drug discovery through advanced phenotypic data analysis and ...

Revvity offers comprehensive solutions designed to help accelerate laboratory workflows, assisting researchers meet targets faster and bring new therapies to market sooner. Our integrated approach ...

Improved content discoverability via Reaxys® Medicinal Chemistry combined with data integration capabilities allow chemists to identify and optimize promising lead candidates Elsevier, a world-leading ...

Workflow Services, a comprehensive and automated platform that solves point-of-care clinical service delivery for pharmacies, was selected by the Food and Drug Administration as a partner in its ...

OpenAI has expanded its genomics and drug discovery model GPT-Rosalind with life-sciences plugins and controlled access.

The comparison between virtual screening and physical screening has become a central topic in modern drug discovery, as laboratories seek to balance efficiency and certainty. Advances in computational ...